Showing results (31-40 of 213) with videos related to
Sort By:
Pageof 22
Journal of Personalized Medicine|June 2, 2021
Real-World Experience of the One-Year Efficacy of Rifaximin Add-On to Lactulose Is Superior to Lactulose Alone in Patients with Cirrhosis Complicated with Recurrent Hepatic Encephalopathy in TaiwanChing Chang, Chien-Hao Huang, Hsiao-Jung Tseng, et al.Digestive Diseases and Sciences|April 23, 2024
Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort StudyMing-Ling Chang, Puo-Hsien Le, Wei-Ting Chen, et al.Journal of Surgical Oncology|August 27, 2005
Clinicopathological features, surgical management, and disease outcome of perforated gastric cancerShyh-Chuan Jwo, Rong-Nan Chien, Tzu-Chien Chao, et al.Hepatology (Baltimore, Md.)|November 7, 2017
Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis BWen-Juei Jeng, Yi-Cheng Chen, Rong-Nan Chien, et al.Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|August 27, 2015
Clearance of Hepatitis C Virus Improves Insulin Resistance During and After Peginterferon and Ribavirin TherapyCheng-Hung Chien, Chih-Lang Lin, Ching-Chih Hu, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 15, 2023
Characteristic geoepidemiology of primary biliary cholangitis in Taiwan: A nationwide population-based studyJur-Shan Cheng, Wei-Ting Chen, Hsin-Ping Ku, et al.JHEP Reports : Innovation in Hepatology|April 22, 2026
Severe Hepatitis Flares After Antiviral Withdrawal in Chronic Hepatitis B With Lymphoma: Impact of RituximabYen-Chun Liu, Yu-Jia Shih, Chao-Wei Hsu, et al.Hepatology International|June 14, 2022
Comparable outcomes of decompensated chronic hepatitis B patients treated with entecavir or tenofovir: an 8-year cohort studyKuan-Chieh Lee, Jur-Shan Cheng, Ming-Ling Chang, et al.The Journal of Antimicrobial Chemotherapy|October 7, 2021
Highly significant differences in HBsAg kinetics among patients with two types of hepatitis B flare, with and without retreatmentWen-Juei Jeng, Yen-Chun Liu, Chien-Wei Peng, et al.Hepatology (Baltimore, Md.)|October 28, 2003
Determinants for sustained HBeAg response to lamivudine therapyRong-Nan Chien, Chau-Ting Yeh, Sun-Lung Tsai, et al.Pageof 22